News and Announcements
Biorithm nominated for Top 20 in “Creating the New Normal” sector of Startup SG’s Slingshot Competition 2020
- Published January 07, 2021 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Biorithm, a startup based in Singapore was awarded a spot in the Top 20 finalists of Startup SG’s Slingshot Competition’s “COVID-19 Challenge: Creating the New Normal” sector. In addition, they made it to the Top 100 Finalists overall, representing one of the Top 20 innovative startups in the MedTech, HealthTech & BioTech sector.
The Slingshot competition is an annual startup competition powered by Startup SG and organized by Enterprise Singapore. This year was its fourth annual edition, and due to the pandemic, the finals at SFF x SWITCH 2020 (Singapore FinTech Festival x Singapore Week of Innovation and Technology) were held virtually to accommodate its very global participants.
This year, the competition was also global and as a result, highly competitive. Biorithm competed with over 7,500 other innovative and globally based startups to receive its place in the Top 20 of two widely sought-out challenge sectors. The Top 100 start-ups were invited for a week of mentorship and pitch clinics, called Gear-Up, which prepared them for the three-day virtual finals.
[Pitch video from Slingshot]
About Biorithm
Biorithm provides innovative maternal-fetal connected care solution to improve pregnancy outcomes for patients and healthcare providers.
Forging new frontiers in pregnancy care, Biorithm has developed cutting edge analytic software together with medical-grade abdominal ECG wearable designed for remote monitoring of maternal & fetal physiological parameters.
Our unique solution allows accurate monitoring of a wide range of vital pregnancy data, empowering patient and clinicians to identify early signs of maternal-fetal complication for timely intervention while reducing the cost of care.
Founded by doctors and engineers, Biorithm is a medical technology start-up spun-off from Nanyang Technological University in Singapore. We believe that comprehensive maternal healthcare should leverage the power of digital health and advanced sensors to address individual patient and clinicians needs, enhance data-driven decisions, complication prevention, and provide access to affordable and preventive care.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
